Sodium phosphate

Drug ingredientActive Shortage

CAS 7632-05-5

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

US productionCBI

Confidential Business Information. The EPA withholds this volume because publishing it could reveal the reporting company's trade secrets.

Top sourceNo public record

At least one company claimed its 2023 production or import volume for this chemical as confidential, so EPA withholds it.

Why supply is unknown

Production is reported production, not a complete census of factories. US production volume is confidential. Production reporting year: 2023.

Where It Comes From

EPA reports by year

2023: US production Confidential · Imports Confidential
2019: US production 226.5K lb · Imports 268 lb

EPA-registered manufacturers (1)

Companies that report making or importing this chemical to the EPA. Registration is US-centric and does not indicate import origin.

Nalco- An Ecolab

4 FDA-registered drug labelers

Hyland's Inc.

Lukare Medical, LLC

PEKANA Naturheilmittel GmbH

Seroyal USA

Why It Matters

Sectors

HealthEnergyMetals & MiningCore Chemicals

Downstream Uses

Appears in 6 drug and cosmetic product listings (FDA).

•Nerve Tonic Stress Relief
•Elliotts B
•Natrium Phosphoricum 6X
•apo-STOM
•Ferrum Phosphate
•Nerve Tonic

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

Active Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

Current shortage
Dexamethasone Sodium Phosphate Injection
Shortage listed since February 8, 2019
Manufacturer reports: 1 unavailable, 1 available

See all current drug shortages

Industrial Uses

Used in 3 sectors as 2 functional roles.

•Intermediate in All Other Chemical Product and Preparation Manufacturing (100%)Processing—incorporation into formulation, mixture, or reaction product
•Anti-scaling agent in All Other Chemical Product and Preparation Manufacturing (9%)Processing—repackaging
•Anti-scaling agent in Oil and Gas Drilling, Extraction, and Support activities (45%)Use—non-incorporative activities
•Anti-scaling agent in Other (2%)Use—non-incorporative activities

Chemical Identity

CAS7632-05-5

PubChem CIDNot recorded

DTXSIDDTXSID3037674

FormulaNot recorded

Mol. WeightNot recorded

SMILESNot recorded

Data Sources

EPA CompTox (DSSTox) · DTXSID3037674Retrieved 2026-04-06
EPA Chemical Data ReportingReporting year: 2023 · Retrieved 2026-10-04
FDA Drug ShortagesRetrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Sodium phosphate (CAS 7632-05-5) https://chemicalindependence.com/chemical/7632-05-5/ EPA CompTox (DSSTox): DTXSID3037674. Retrieved 2026-04-06. https://comptox.epa.gov/dashboard/chemical/details/DTXSID3037674 EPA Chemical Data Reporting: 7632-05-5. Reporting year: 2023. https://www.epa.gov/chemical-data-reporting FDA Drug Shortages: CAS 7632-05-5. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/